Home Medicinal chemistry Enveda Appoints Pharmacy Veteran Vanitha Sekar as Chief Commercial Officer

Enveda Appoints Pharmacy Veteran Vanitha Sekar as Chief Commercial Officer


BOULDER, Colorado–(BUSINESS WIRE)–Enveda Biosciences, a pioneer in transforming small molecule drug discovery using machine learning and metabolomics to unlock the potential of natural products, today announced the appointment of Vanitha Sekar, Ph.D. ., R.Ph., to the new position of Commercial Director. Dr. Sekar will play a key role in Enveda’s continued growth and will be responsible for shaping the company’s business development strategy.

Dr. Sekar brings to Enveda more than 20 years of experience in business development, corporate strategy and R&D in the pharmaceutical and biotechnology fields. She joins Enveda from Gilead Sciences Inc., the global biopharmaceutical company, where she was responsible for business development for its flagship therapeutic area of ​​virology.

Prior to joining Gilead, Dr. Sekar was Executive Director, Business Development & Licensing, for Merck Research Laboratories. Prior to joining Merck, she held several roles at Janssen Pharmaceuticals, including business development and R&D, and led the evaluation of multiple opportunities with cross-functional teams and business partners. During her career, she has completed numerous transactions for preclinical and clinical stage assets.

Dr. Sekar also helped develop and execute strategies for new chemical entity development, lifecycle management, and post-marketing of HIV and Hepatitis B and C drugs. Prior to his tenure at Johnson & Johnson, she led clinical pharmacology at Tibotec US, which was acquired by J&J and became part of Janssen Pharmaceuticals.

Dr. Sekar also spent five years as the Acting Team Leader and Senior Reviewer for Antiviral and Neuropharmacology Drugs at the United States Food and Drug Administration. She received her Ph.D. in Pharmaceutical Sciences from Virginia Commonwealth University and a Bachelor of Pharmacy from Birla Institute of Technology and Sciences, Pilani.

“Vanitha is an exceptionally experienced and knowledgeable pharma and biotech executive who has forged key partnerships in our industry and understands it well,” said Viswa Colluru, Ph.D., CEO of Enveda. “We are delighted to welcome Vanitha to Enveda, where her 20 years of experience creating value for companies, their partners and their investors is a key addition to our team and our business efforts. She joins Enveda at a fantastic time as we are making significant and rapid progress with our platform and our pipeline is showing great progress. We all look forward to working with Vanitha as we continue our work to bring hope to patients around the world.

Dr. Sekar brings to his new role at Enveda a wealth of scientific background, a passion for patients, extensive drug development experience and acumen for business.

“Growing up and studying to be a pharmacist in India, I learned to appreciate and respect herbal medicines for their therapeutic properties,” Dr. Sekar said. “Therefore, joining the Enveda family is very much like stepping back to the future. I am thrilled to join a company that is on its way to revolutionizing drug discovery by integrating machine learning and metabolomics to turn natural products into Equally important, I am privileged to have the opportunity to partner with Viswa and his uniquely talented team.

Dr. Sekar’s commitment to the healthcare industry extends to his passion for recruiting, mentoring and supporting women and minorities in early career and leadership roles. She is a member of the life sciences board of Springboard Enterprises, the premier platform for building great women-led businesses and a member of BIO’s Healthcare Businesswomen’s Association.

“Vanitha’s impact can be seen not only in the companies she has worked with, but also in her influence on efforts to mentor women in our industry. We look forward to doing a great job together at Enveda,” said Dr. Colluru.

About Enveda Biosciences

Enveda Biosciences is a biotechnology company building the first high-resolution chemical map of the natural world to tackle the toughest problems in drug discovery. Enveda’s platform is the world’s most advanced drug discovery search engine for the nearly limitless breadth of nature’s unknown chemistry, building on years of cutting-edge advances at the intersection metabolomics and machine learning. Complementing its breakthrough technology, Enveda’s team includes seasoned drug hunters with decades of pharmaceutical industry experience working alongside world-renowned data scientists. For more information about Enveda, visit envedabio.com.